Dr Asnani is Associate Director and an attending physician in the Cardio-Oncology Program at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts and is an active researcher in the field. She joined BIDMC in 2017 and prior to this worked at the Massachusetts General Hospital. She earned her medical degree at the Duke School of Medicine, Durham, North Carolina in 2008, one of the nation’s top medical schools.
Her interests lie in the molecular mechanisms responsible for chemotherapy-induced heart toxicity, a major contributor to morbidity and mortality in the growing population of cancer survivors. Her research interests include the molecular pathways contributing to heart failure induced by a commonly used chemotherapy, doxorubicin.
Articles by Aarti Asnani, MD
Aarti Asnani, Randall T Peterson,
Citation: US Cardiology Review 2017;11(1):20–4